Dosing regimen of reteplase and costeffectiveness
- PMID: 11705534
- DOI: 10.1016/S0140-6736(01)06513-8
Dosing regimen of reteplase and costeffectiveness
Comment on
-
Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial.Lancet. 2001 Jun 16;357(9272):1905-14. doi: 10.1016/s0140-6736(00)05059-5. Lancet. 2001. PMID: 11425410 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
